CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation

Europace

Volumn 16, Issue 2, 2014, Pages 202-207

  Letsas, Konstantinos P ^a   Efremidis, Michael ^a   Giannopoulos, Georgios ^b   Deftereos, Spyridon ^b   Lioni, Louiza ^a   Korantzopoulos, Panagiotis ^c   Vlachos, Konstantinos ^a   Xydonas, Sotirios ^a   Kossyvakis, Charalampos ^b   Sideris, Antonios ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Atrial fibrillation; Catheter ablation; CHA 2DS2 VASc score; CHADS2 score; Recurrence

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPAFENONE; SOTALOL;

ABLATION CATHETER; ADULT; AREA UNDER THE CURVE; ARTICLE; CATHETER ABLATION; CHA2DS2 VASC SCORE; CHADS2 SCORE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART TAMPONADE; HEART VOLUME; HEMATOMA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; MIDDLE AGED; OUTCOME ASSESSMENT; PERICARDIOCENTESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; TRANSIENT ISCHEMIC ATTACK; AGED; CHA2DS2-VASC SCORE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; DISEASE FREE SURVIVAL; HEART ATRIUM; HEART ATRIUM FUNCTION; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; CHA2DS2-VASC SCORE; CHADS2 SCORE; RECURRENCE;

AGED; AREA UNDER CURVE; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; FEMALE; HEART ATRIA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893219776     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut210     Document Type: Article

References (19)

1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/ EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
2. Berruezo A, Tamborero D, Mont L, Benito B, Tolosana JM, Sitges M et al. Preprocedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 2007;28:836-41.
3. Letsas KP,Weber R, Bürkle G, Mihas CC, Minners J, Kalusche D et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace 2009;11:158-63.
4. Deftereos S, Giannopoulos G, Kossyvakis C, EfremidisM, Panagopoulou V, KaoukisA et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J AmColl Cardiol 2012;60:1790-6.
5. Boriani G, Botto GL, Padeletti L, Santini M, Capucci A, GuliziaMet al. Italian AT-500 Registry Investigators. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 2011;42:1768-70.
6. Lip G.Y., Nieuwlaat R, PistersR,LaneDA,CrijnsHJ.Refining clinical risk stratificationfor predicting stroke and thromboembolism in atrial fibrillation using a novel risk factorbased approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72.
7. Chao TF, Cheng CC, LinWS,TsaoHM,Lin YJ, Chang SL et al. Associationsamong the CHADS(2) score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm 2011;8:1155-9.
8. Chao TF, Lin YJ, Tsao HM, Tsai CF, Lin WS, Chang SL et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 2011;58:2380-5.
9. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management ofAtrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al.; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
11. Chao TF, Ambrose K, Tsao HM, Lin YJ, Chang SL, Lo LWet al. Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm 2012;9:1185-91.
12. Park JH, Joung B, Son NH, Shim JM, Lee MH, Hwang C et al. The electroanatomical remodelling of the left atrium is related to CHADS2/CHA2DS2VASc score and events of stroke in patients with atrial fibrillation. Europace 2011;13:1541-9.
13. Akoum N, Daccarett M,McGann C, Segerson N, Vergara G, Kuppahally S et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol 2011;22:16-22.
14. Maehama T, Okura H, Imai K, Yamada R, Obase K, Saito K et al. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation. Am J Cardiol 2010;106:535-8.
15. Daccarett M, Badger TJ, Akoum N, Burgon NS, Mahnkopf C, Vergara G et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J AmColl Cardiol 2011; 57:831-8.
16. Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep 2013;13:435-44.
17. Signorelli SS, Anzaldi M, Fiore V. Inflammation in peripheral arterial disease (PAD). Curr Pharm Des 2012;18:4350-7.
18. Wrigley BJ, Lip G.Y., Shantsila E. The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 2011;13:1161-71.
19. Crowley SD. The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal 2013 (Epub ahead of print; Mar 9), doi:10.1089/ars.2013.5258.